Regulatory filings are under review in the U.S., Europe, Canada and Australia, with potential approvals expected to ...

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.

Randomized trial shows superiority in adults 50 and older ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a ...

The recent hantavirus outbreak has terrified people around the world, and understandably so. More than anything, however, ...

In a recent article published in Pediatrics, researchers presented the results of their rapid cycle analysis (RCA) safety surveillance, which is a weekly surveillance monitoring of monovalent ...